In the BioHarmony Drug Report Database
Guanidine
Guanidine (guanidine) is a small molecule pharmaceutical. Guanidine was first approved as Guanidine on 1982-01-01. It is used to treat lambert-eaton myasthenic syndrome and muscle weakness in the USA. It is known to target acid-sensing ion channel 3 and nitric oxide synthase, inducible.
Trade Name
|
Guanidine |
|---|---|
Common Name
|
guanidine |
ChEMBL ID
|
CHEMBL821 |
Indication
|
lambert-eaton myasthenic syndrome, muscle weakness |
Drug Class
|
Antihypertensives (guanidine derivatives) |
Image (chem structure or protein)